Literature DB >> 30323022

Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells.

Jie Yang1, Alan Pemberton1, W Ivan Morrison2, Tim Connelley1.   

Abstract

There is established evidence that cytotoxic CD8+ T cells are important mediators of immunity against the bovine intracellular protozoan parasite Theileria parva However, the mechanism by which the specific CD8+ T cells kill parasitized cells is not understood. Although the predominant pathway used by human and murine CD8+ T cells to kill pathogen-infected cells is granule exocytosis, involving the release of perforin and granzyme B, there is to date a lack of published information on the biological activities of bovine granzyme B. The present study set out to define the functional activities of bovine granzyme B and determine its role in mediating the killing of T. parva-parasitized cells. DNA constructs encoding functional and nonfunctional forms of bovine granzyme B were produced, and the proteins expressed in Cos-7 cells were used to establish an enzymatic assay to detect and quantify the expression of functional granzyme B protein. Using this assay, the levels of killing of different T. parva-specific CD8+ T cell clones were found to be significantly correlated with the levels of granzyme B protein but not the levels of mRNA transcript expression. Experiments using inhibitors specific for perforin and granzyme B confirmed that CD8+ T cell killing of parasitized cells is dependent on granule exocytosis and, specifically, granzyme B. Further studies showed that the granzyme B-mediated death of parasitized cells is independent of caspases and that granzyme B activates the proapoptotic molecule Bid.
Copyright © 2018 Yang et al.

Entities:  

Keywords:  T cells; Theileria parvazzm321990; cattle; cytotoxicity; granzyme B; substrate specificity

Mesh:

Substances:

Year:  2018        PMID: 30323022      PMCID: PMC6300629          DOI: 10.1128/IAI.00386-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  The major human and mouse granzymes are structurally and functionally divergent.

Authors:  Dion Kaiserman; Catherina H Bird; Jiuru Sun; Antony Matthews; Kheng Ung; James C Whisstock; Philip E Thompson; Joseph A Trapani; Phillip I Bird
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

2.  Identification and characterization of equine granzyme B.

Authors:  Konrad Piuko; Ignacio G Bravo; Martin Müller
Journal:  Vet Immunol Immunopathol       Date:  2007-06-03       Impact factor: 2.046

3.  Memory CD8+ T cells protect dendritic cells from CTL killing.

Authors:  Payal B Watchmaker; Julie A Urban; Erik Berk; Yutaro Nakamura; Robbie B Mailliard; Simon C Watkins; S Marieke van Ham; Pawel Kalinski
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

4.  Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B.

Authors:  Sami Mahrus; Walter Kisiel; Charles S Craik
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

5.  Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

Authors:  X Luo; I Budihardjo; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

6.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B.

Authors:  Catherine Ewen; Kevin P Kane; Irene Shostak; Philip J Griebel; Edward M Bertram; Tania H Watts; R C Bleackley; Janet E McElhaney
Journal:  J Immunol Methods       Date:  2003-05-01       Impact factor: 2.303

Review 7.  Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.

Authors:  D E Jenne; J Tschopp
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

8.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Authors:  Felipe Andrade; Edward Fellows; Dieter E Jenne; Antony Rosen; C S H Young
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

9.  Definition and redesign of the extended substrate specificity of granzyme B.

Authors:  J L Harris; E P Peterson; D Hudig; N A Thornberry; C S Craik
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  Identification and annotation of bovine granzyme genes reveals a novel granzyme encoded within the trypsin-like locus.

Authors:  Jie Yang; Christina Vrettou; Tim Connelley; W Ivan Morrison
Journal:  Immunogenetics       Date:  2018-06-08       Impact factor: 2.846

View more
  5 in total

1.  Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.

Authors:  Mary K McKenna; Alexander Englisch; Benjamin Brenner; Tyler Smith; Valentina Hoyos; Masataka Suzuki; Malcolm K Brenner
Journal:  Mol Ther       Date:  2021-02-09       Impact factor: 11.454

Review 2.  Immune Response to Tick-Borne Hemoparasites: Host Adaptive Immune Response Mechanisms as Potential Targets for Therapies and Vaccines.

Authors:  Alessandra Torina; Valeria Blanda; Sara Villari; Antonio Piazza; Francesco La Russa; Francesca Grippi; Marco Pio La Manna; Diana Di Liberto; José de la Fuente; Guido Sireci
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 3.  Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors.

Authors:  Violena Pietrobon; Alessandra Cesano; Francesco Marincola; Jakob Nikolas Kather
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

Review 4.  Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment.

Authors:  Weinan Wang; Rui Zou; Ye Qiu; Jishuang Liu; Yu Xin; Tianzhu He; Zhidong Qiu
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

5.  Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma.

Authors:  Tiangen Wu; Yang Ke; Haoran Tang; Chen Liao; Jinze Li; Lin Wang
Journal:  Mol Ther Oncolytics       Date:  2021-06-12       Impact factor: 7.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.